Literature DB >> 3112356

Evaluation of factors in high risk neonatal necrotizing enterocolitis.

C J McCormack, R W Emmens, T C Putnam.   

Abstract

Fifty-four neonates with necrotizing enterocolitis (NEC) were separated on basis of outcome. Of 35 factors compared between a high-risk and a low-risk group, only six were found to be statistically significant and useful in the development of a NEC score: number of days before beginning enteral feedings; blood pH; serum bicarbonate concentration; white blood cell differential; abdominal tenderness; and presence of portal vein gas. All laboratory values and physical and radiographic findings were from the initial presentation of NEC. Neonates with a score of 3 or more are at an increased risk of developing severe NEC with a greater than 50% mortality. The study suggests that enteral feedings should be withheld from neonates at risk of developing NEC for the first 12 days of life.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112356     DOI: 10.1016/s0022-3468(87)80202-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  3 in total

1.  Temporal and seasonal variations in incidence of stage II and III NEC-a 28-year epidemiologic study from tertiary NICUs in Connecticut, USA.

Authors:  Darius Javidi; Zigeng Wang; Sanguthevar Rajasekaran; Naveed Hussain
Journal:  J Perinatol       Date:  2021-02-15       Impact factor: 2.521

Review 2.  Neonatal necrotising enterocolitis.

Authors:  M Rohatgi; S Chandna
Journal:  Indian J Pediatr       Date:  1988 Nov-Dec       Impact factor: 1.967

3.  A data-driven algorithm integrating clinical and laboratory features for the diagnosis and prognosis of necrotizing enterocolitis.

Authors:  Jun Ji; Xuefeng B Ling; Yingzhen Zhao; Zhongkai Hu; Xiaolin Zheng; Zhening Xu; Qiaojun Wen; Zachary J Kastenberg; Ping Li; Fizan Abdullah; Mary L Brandt; Richard A Ehrenkranz; Mary Catherine Harris; Timothy C Lee; B Joyce Simpson; Corinna Bowers; R Lawrence Moss; Karl G Sylvester
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.